Oncternal Therapeutics, Inc. ONCT
0.53 0.00 (+0.00%)
At closeDec 2, 2024, 4:00 PM EST
0.5266 Day range 0.70
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 785.00K | 1.49M | 4.32M | 3.38M | 2.42M | |
| 785.00K | 1.49M | 4.32M | 3.38M | 2.42M | |
| -41.71M | -44.95M | -31.37M | -17.54M | -33.11M | |
| -39.48M | -44.17M | -31.33M | -17.23M | -34.19M | |
| -13.43 | -16.80 | -12.80 | -17.00 | -66.20 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 6.70M | 37.14M | 90.77M | 116.74M | 20.05M | |
| 36.73M | 68.65M | 93.58M | 118.81M | 21.74M | |
| 6.68M | 7.68M | 5.46M | 5.86M | 7.43M | |
| 318.00K | 87.00K | 75.00K | 40.00K | 190.00K | |
| 30.05M | 60.97M | 88.12M | 112.95M | 14.31M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -32.16M | -36.70M | -26.59M | -17.50M | -16.75M | |
| 651.00K | -26.50M | 0 | 0 | 16.14M | |
| 1.07M | 9.58M | 617.00K | 114.18M | 15.00K | |
| -30.45M | -53.62M | -25.97M | 96.69M | -594.00K |